ub8体育平台

<input id="uoa60"><acronym id="uoa60"></acronym></input>
<input id="uoa60"></input>
  • <menu id="uoa60"></menu>
  • <input id="uoa60"></input>
    <menu id="uoa60"></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <object id="uoa60"><acronym id="uoa60"></acronym></object>
  • <input id="uoa60"></input>
    <menu id="uoa60"><u id="uoa60"></u></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <menu id="uoa60"><u id="uoa60"></u></menu>
  • <input id="uoa60"><u id="uoa60"></u></input>
  • 财新传媒
    财新英文 > 要闻 > 正文

    It’s Too Early to Get Excited About Gilead’s New Coronavirus Drug, Experts Say

    2020年02月07日 20:33 来源于 财新网
    Although remdesivir so far appears to be more effective at fighting the deadly virus than other antivirals, the evidence remains light
    Experts say Gilead’s drug remdesivir looks promising, but that it’s far too early to get excited. Photo: IC Photo

    Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.

    版面编辑:喻竹杨洋
    财新私房课
    好课推荐
    
    <input id="uoa60"><acronym id="uoa60"></acronym></input>
    <input id="uoa60"></input>
  • <menu id="uoa60"></menu>
  • <input id="uoa60"></input>
    <menu id="uoa60"></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <object id="uoa60"><acronym id="uoa60"></acronym></object>
  • <input id="uoa60"></input>
    <menu id="uoa60"><u id="uoa60"></u></menu><input id="uoa60"><u id="uoa60"></u></input>
  • <menu id="uoa60"><u id="uoa60"></u></menu>
  • <input id="uoa60"><u id="uoa60"></u></input>
  • 7k的彩是值得您信赖

    中国福彩下载app下载

    拉菲娱乐注册网址

    中博的彩舒适

    机选一注摇一摇

    天福彩票网址

    摩卡平台娱乐

    澳门葡京赌场官方网站

    m8的彩